Search research articles
Contact Us
Filters
Showing results (61-70 of 77) with videos related to
Page
of 8
Sort By:
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America
|
January 21, 2016
Ruxolitinib Induces Interleukin 17 and Ameliorates Chronic Mucocutaneous Candidiasis Caused by STAT1 Gain-of-Function Mutation
Rotraut Mössner, Nina Diering, Oliver Bader, et al.
FEMS Microbiology Letters
|
September 3, 2002
Monocyte chemotactic protein-1 secretion and expression after Toxoplasma gondii infection in vitro depend on the stage of the parasite
Marie-Pierre Brenier-Pinchart, Inés Vigan, Evelyne Jouvin-Marche, et al.
Critical Reviews in Microbiology
|
June 12, 2009
Immunity to Campylobacter: its role in risk assessment and epidemiology
Arie H Havelaar, Wilfrid van Pelt, C Wim Ang, et al.
Emerging Infectious Diseases
|
October 18, 2011
Bacteremia and antimicrobial drug resistance over time, Ghana
Uwe Gross, Sylvarius K Amuzu, Ring de Ciman, et al.
Antimicrobial Agents and Chemotherapy
|
May 23, 2012
Facultative sterol uptake in an ergosterol-deficient clinical isolate of Candida glabrata harboring a missense mutation in ERG11 and exhibiting cross-resistance to azoles and amphotericin B
Claire M Hull, Josie E Parker, Oliver Bader, et al.
ALTEX
|
February 15, 2001
[Characteristics of Toxoplasma-gondii-tachyzoites from different culture systems]
Harald Klein, Martina Anduleit, Monika Bornhak, et al.
Antimicrobial Agents and Chemotherapy
|
June 16, 2010
A clinical isolate of Candida albicans with mutations in ERG11 (encoding sterol 14alpha-demethylase) and ERG5 (encoding C22 desaturase) is cross resistant to azoles and amphotericin B
Claire M Martel, Josie E Parker, Oliver Bader, et al.
Antimicrobial Agents and Chemotherapy
|
October 3, 2012
Two clinical isolates of Candida glabrata exhibiting reduced sensitivity to amphotericin B both harbor mutations in ERG2
Claire M Hull, Oliver Bader, Josie E Parker, et al.
Antimicrobial Agents and Chemotherapy
|
August 25, 2010
Identification and characterization of four azole-resistant erg3 mutants of Candida albicans
Claire M Martel, Josie E Parker, Oliver Bader, et al.
Plos One
|
January 4, 2013
Gross karyotypic and phenotypic alterations among different progenies of the Candida glabrata CBS138/ATCC2001 reference strain
Oliver Bader, Alexander Schwarz, Eefje A Kraneveld, et al.
Page
of 8
Search research articles
Search
Showing results (61-70 of 77) with videos related to
Sort By:
Page
of 8
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America
|
January 21, 2016
Ruxolitinib Induces Interleukin 17 and Ameliorates Chronic Mucocutaneous Candidiasis Caused by STAT1 Gain-of-Function Mutation
Rotraut Mössner, Nina Diering, Oliver Bader, et al.
FEMS Microbiology Letters
|
September 3, 2002
Monocyte chemotactic protein-1 secretion and expression after Toxoplasma gondii infection in vitro depend on the stage of the parasite
Marie-Pierre Brenier-Pinchart, Inés Vigan, Evelyne Jouvin-Marche, et al.
Critical Reviews in Microbiology
|
June 12, 2009
Immunity to Campylobacter: its role in risk assessment and epidemiology
Arie H Havelaar, Wilfrid van Pelt, C Wim Ang, et al.
Emerging Infectious Diseases
|
October 18, 2011
Bacteremia and antimicrobial drug resistance over time, Ghana
Uwe Gross, Sylvarius K Amuzu, Ring de Ciman, et al.
Antimicrobial Agents and Chemotherapy
|
May 23, 2012
Facultative sterol uptake in an ergosterol-deficient clinical isolate of Candida glabrata harboring a missense mutation in ERG11 and exhibiting cross-resistance to azoles and amphotericin B
Claire M Hull, Josie E Parker, Oliver Bader, et al.
ALTEX
|
February 15, 2001
[Characteristics of Toxoplasma-gondii-tachyzoites from different culture systems]
Harald Klein, Martina Anduleit, Monika Bornhak, et al.
Antimicrobial Agents and Chemotherapy
|
June 16, 2010
A clinical isolate of Candida albicans with mutations in ERG11 (encoding sterol 14alpha-demethylase) and ERG5 (encoding C22 desaturase) is cross resistant to azoles and amphotericin B
Claire M Martel, Josie E Parker, Oliver Bader, et al.
Antimicrobial Agents and Chemotherapy
|
October 3, 2012
Two clinical isolates of Candida glabrata exhibiting reduced sensitivity to amphotericin B both harbor mutations in ERG2
Claire M Hull, Oliver Bader, Josie E Parker, et al.
Antimicrobial Agents and Chemotherapy
|
August 25, 2010
Identification and characterization of four azole-resistant erg3 mutants of Candida albicans
Claire M Martel, Josie E Parker, Oliver Bader, et al.
Plos One
|
January 4, 2013
Gross karyotypic and phenotypic alterations among different progenies of the Candida glabrata CBS138/ATCC2001 reference strain
Oliver Bader, Alexander Schwarz, Eefje A Kraneveld, et al.
Page
of 8